Progress and challenges in Nipah vaccine development and licensure for epidemic preparedness and response

Introduction Nipah virus is a high-consequence pathogen that causes sporadic outbreaks with high mortality, and there are currently no vaccines or therapeutics available for Nipah. Vaccine development against Nipah faces challenges due to its current epidemiology with limited outbreak sizes, which i...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Sol Kim, Hyolim Kang, Laura Skrip, Sushant Sahastrabuddhe, Ausraful Islam, Sung-Mok Jung, Juan F. Vesga, Akira Endo, W. John Edmunds, Kaja Abbas
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Taylor & Francis Group 2025-12-01
סדרה:	Expert Review of Vaccines
נושאים:	Alternative regulatory pathway Nipah virus Henipavirus nipahense pandemic preparedness vaccine efficacy trials vaccine licensure
גישה מקוונת:	https://www.tandfonline.com/doi/10.1080/14760584.2025.2476523
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!